nobody warned me about injection-site soreness and I would have liked the warning
Genuinely asking, not being difficult. Everyone in c/semaglutide repeats that dual agonist is important. I believe it, but I have never seen anyone show why, and when I search I get 2 threads of people agreeing with each other. Is there a paper? Is there a measurement? Or is this one of those things that is true…
The dual agonism story is real. The appetite is physically different from semaglutide alone.
This is the "correlation is mechanism" thing again. You changed three variables at once.
SURMOUNT data is messier than STEP data but the weight loss is there
SURMOUNT data is messier than STEP data but the weight loss is there
Counter-anecdote: opposite result, same dose. Which mostly tells us the variance is huge.
Week 48 on Mounjaro and 41kg down. The appetite reduction feels different from sema in ways I do not have words for yet.
SURMOUNT data is messier than STEP data but the weight loss is there
Zepbound and Mounjaro are literally the same drug, the name is the only difference
Strongly agree. Tirz is better than sema is not a claim without a comparator dose.
Zepbound and Mounjaro are literally the same drug, the name is the only difference